Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: Studies using the ecdysone inducible expression system

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 376, Issue 3, 2007, Pages 217-225

  Barnes, T A ^a   McDonald, J ^a   Rowbotham, D J ^a   Duarte, T L ^a   Lambert, D G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Desensitisation; Inducible expression; Nociceptin Orphanin FQ; Nociceptin Orphanin FQ receptor; Quantitative PCR; Second messengers

Indexed keywords

CELL SURFACE RECEPTOR; CYCLIC AMP; ECDYSONE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; NOCICEPTIN; NOCICEPTIN RECEPTOR; PONASTERONE A; SULFUR 35;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CENTRAL NERVOUS SYSTEM; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE INDUCTION; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; ECDYSONE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); OPIOID PEPTIDES; RECEPTORS, OPIOID; RNA, MESSENGER;

EID: 35648995946     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0189-z     Document Type: Article

References (37)

1. Andressen KW, Norum JH, Levy FO, Krobert KA (2006) Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression. Mol Pharmacol 69:207-215
2. Bailey CP, Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68
3. Calo G, Guerrini R, Rizzi A, Salvadri S, Regoli D (2000) Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 129:1261-1283
4. Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL (1997) Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res 45:149-153
5. Chavkin C, McLaughlin JP, Celver JP (2001) Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol Pharmacol 60:20-25
6. Cheng ZJ, Fan GH, Zhao J, Zhang Z, Wu YL, Jiang LZ, Zhu Y, Pei G, Ma L (1997) Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization. Neuroreport 8:1913-1918
7. Connor M, Vaughan CW, Chieng B, Christie MJ (1996) Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol 119:1614-1618
8. Connor M, Osborne PB, Christie MJ (2004) Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol 143:685-696
9. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144
10. Gavioli EC, Calo G (2006) Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn. Schmiedebergs Arch Pharmacol 372:319-330
11. Gintzler AR, Chakrabarti S (2006) Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules. Life Sci 79:717-722
12. Hashiba E, Harrison C, Galo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG (2001) Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor. Naunyn. Schmiedebergs Arch Pharmacol 363:28-33
13. Hashimoto Y, Calo G, Guerrini R, Smith G, Lambert DG (2002) Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors. Eur J Pharmacol 449:17-22
14. Hawes BE, Graziano MP, Lambert DG (2000) Cellular actions of nociceptin: transduction mechanisms. Peptides 21:961-967
15. Johnson EE, Chieng B, Napier I, Connor M (2006) Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Br J Pharmacol 148:947-955
16. Kim MS, Cheong YP, So HS, Lee KM, Son Y, Lee CS, Yun JS, Park R (2002) Regulation of cyclic AMP-dependent response element-binding protein (CREB) by the nociceptin/orphanin FQ in human dopaminergic SH-SY5Y cells. Biochem Biophys Res Commun 291:663-668
17. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, Loh HH (2000) Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275:32057-32065
18. Ma L, Pei G (2007) Beta-arrestin signaling and regulation of transcription. J Cell Sci 120:213-218
19. Ma L, Cheng ZJ, Fan GH, Cai YC, Jiang LZ, Pei G (1997) Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells. FEBS Lett 403:91-94
20. Marie N, Aguila B, Allouche S (2006) Tracking the opioid receptors on the way of desensitization. Cell Signal 18:1815-1833
21. McDonald J, Barnes TA, Okawa H, Williams J, Calo G, Rowbotham DJ, Lambert DG (2003) Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone-inducible mammalian expression system. Br J Pharmacol 140:61-70
22. Meunier J (2000) The potential therapeutic value of nociceptin receptor agonists and antagonists. Exp Opin Ther Patents 10:371-388
23. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B et al (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535
24. Mogil JS, Pasternak GW (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53:381-415
25. 2+ channel inhibition and its desensitization in NG108-15 cells. Eur J Pharmacol 351:247-252
26. New DC, Wong YH (2002) The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 11:197-212
27. No D, Yao TP, Evans RM (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93:3346-3351
28. Oehme I, Bosser S, Zornig M (2006) Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. Cell Death Differ 13:189-201
29. Okawa H, Hirst RA, Smart D, McKnight AT, Lambert DG (1998) Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation. Neurosci Lett 246:49-52
30. Pei G, Ling K, Pu L, Cunningham MD, Ma L (1997) Nociceptin/orphanin FQ stimulates extracellular acidification and desensitization of the response involves protein kinase C. FEBS Lett 412:253-256
31. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-794
32. Spampinato S, Di Toro R, Qasem AR (2001) Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells. Neuroreport 12:3159-3163
33. Spampinato S, Baiula M, Calienni M (2007) Agonist-regulated internalization and desensitization of the human nociceptin receptor expressed in CHO cells. Curr Drug Targets 8:137-146
34. Thakker DR, Standifer KM (2002) Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology 43:979-990
35. Violin JD, Dewire SM, Barnes WG, Lefkowitz RJ (2006) G protein-coupled receptor kinase and beta-arrestin-mediated desensitization of the angiotensin II type 1A receptor elucidated by diacylglycerol dynamics. J Biol Chem 281:36411-36419
36. Wu EH, Lo RK, Wong YH (2003) Regulation of STAT3 activity by G16-coupled receptors. Biochem Biophys Res Commun 303:920-925
37. Zeilhofer HU, Calo G (2003) Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy? J Pharmacol Exp Ther 306:423-429